Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
基本信息
- 批准号:8089431
- 负责人:
- 金额:$ 33.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAntigen-Presenting CellsAntigensBacterial AdhesinsBone MarrowCD80 geneCardiovascular DiseasesCell physiologyCellsCholesterolCyclodextrinsCytokine ActivationDendritic CellsDevelopmentDiseaseEffector CellEstersEventExposure toFamilyFluoresceinFluorescein-5-isothiocyanateFutureGlycogen Synthase Kinase 3GoalsHemagglutininHistocompatibility Antigens Class IIIL2RA geneImmuneImmune responseImmune systemImmunityImmunizationInfectionInfection preventionInflammationInflammatoryIntravenousInvestigationIsothiocyanatesKnock-outLeadLigandsLinkLipopolysaccharidesMacrophage Colony-Stimulating FactorMajor Histocompatibility ComplexMediatingMembrane MicrodomainsMitogen-Activated Protein KinasesMolecularMonoclonal AntibodiesNatural ImmunityOvalbuminOvumPathogenesisPathologicPatternPattern recognition receptorPeriodontal DiseasesPhycoerythrinPlasma Membrane Lipid BilayerPlayPorphyromonasPorphyromonas gingivalisProcessProductionPropertyRegulationRegulatory T-LymphocyteRoleSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSpecificityT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTNFSF11 geneTestingToll-like receptorsTumor necrosis factor receptor 11bUp-RegulationVaccine TherapyVirulenceVirulence Factorsadaptive immunitybasecarboxyfluoresceincytokinegingipainimmunoregulationinnovationinsightmacrophagemicroorganismmicroorganism antigenmonocytenovelpathogenreceptorresearch studyresponsesubcutaneoustherapeutic vaccinetherapy developmentvaccine development
项目摘要
DESCRIPTION (provided by applicant): The innate and adaptive immune systems are irrevocably linked and both play primary roles in the induction and/or prevention of infections, including periodontal disease. Critical to the initiation of innate and adaptive immune responses to microbial antigens is the participation of Toll-like receptors (TLRs), a family of pattern- recognition receptors (PRRs) that detect conserved molecular products of microorganisms. We propose that the immune regulation exerted by the innate immune system upon its interaction with virulence antigens is the basis for the development of therapies geared to manipulate the effector immune response to the advantage and protection of the host. The fundamental hypothesis of our studies is that each microbial antigen is unique in its initial interaction with the host, thus resulting in differences in receptor recognition, activation of signaling pathways and cellular responses. In this regard, we have shown differences in the adaptive immune responses to the hemagglutinin/adhesin virulence antigens Kgp-HArep and HagB derived from Porphyromonas ginigivalis, which suggest that their interactions with the innate immune system differ. We plan to focus our investigations on the TLRs and on dendritic cells since these antigen-presenting cells have the exquisite property of activating na¿ve T cells and thus are critically involved in innate and adaptive responses. In addition, our investigations will pursue an understanding of the ensuing adaptive immune response. Therefore, the aims of this proposal are (1) to determine the role of TLRs in the innate and adaptive response to Kgp-HArep and HagB stimulation; (2) to determine if innate and effector cell responses to Kgp- HArep and HagB require lipid rafts and how the induction of a specific effector response or the use of a certain TLR affects the particular recruitment and concentration of signaling molecules into lipid rafts; and (3) to determine the role of CD25+CD4+ Treg cells in immune responses to Kgp-HArep and HagB and in P. gingivalis infection. It is anticipated that these studies will lead to an understanding of the cellular events that occur when host cells encounter the virulence antigens HArep and HagB, and will provide 1) insight into their role in pathogenesis/immunity and 2) relavant information for the development of vaccines or therapies that will specifically protect or ameliorate infections by the pathogen Porphyromonas gingivalis. Porphyromonas gingivalis is a major etiologic agent of periodontal disease. This inflammatory disease is widespread and associations have been made between this disease and serious systemic conditions such as cardiovascular diseases. Since the immunoregulatory properties of P. gingivalis antigens in host responses are poorly understood, it becomes critical to understand the host cellular responses, including the signaling pathways activated, to major antigens of P. gingivalis, in order to develop novel therapies and vaccines by which periodontal disease can be ameliorated or controlled.
描述(由申请人提供):先天性免疫系统和适应性免疫系统是不可逆转地联系在一起的,并且两者在诱导和/或预防感染(包括牙周病)中都发挥着主要作用。 Toll 样受体 (TLR) 是启动针对微生物抗原的先天性和适应性免疫反应的关键,TLR 是模式识别受体 (PRR) 家族,可检测微生物的保守分子产物。我们认为,先天免疫系统在与毒力抗原相互作用时所施加的免疫调节是开发旨在操纵效应免疫反应以利于和保护宿主的疗法的基础。我们研究的基本假设是,每种微生物抗原在与宿主的初始相互作用中都是独特的,从而导致受体识别、信号通路激活和细胞反应的差异。在这方面,我们已经表明对源自牙龈卟啉单胞菌的血凝素/粘附素毒力抗原 Kgp-HArep 和 HagB 的适应性免疫反应存在差异,这表明它们与先天免疫系统的相互作用不同。我们计划将研究重点放在 TLR 和树突状细胞上,因为这些抗原呈递细胞具有激活幼稚 T 细胞的优良特性,因此在先天性和适应性反应中发挥着重要作用。此外,我们的研究将寻求对随后的适应性免疫反应的了解。因此,该提案的目的是(1)确定TLRs在对Kgp-HArep和HagB刺激的先天和适应性反应中的作用; (2) 确定对 Kgp-HArep 和 HagB 的先天细胞和效应细胞反应是否需要脂筏,以及特定效应反应的诱导或特定 TLR 的使用如何影响信号分子进入脂筏的特定募集和浓度; (3)确定CD25+CD4+Treg细胞在针对Kgp-HArep和HagB的免疫应答以及牙龈卟啉单胞菌感染中的作用。预计这些研究将有助于了解宿主细胞遇到毒力抗原 HArep 和 HagB 时发生的细胞事件,并将提供 1) 深入了解它们在发病机制/免疫中的作用,以及 2) 开发专门保护或改善病原体牙龈卟啉单胞菌感染的疫苗或疗法的相关信息。牙龈卟啉单胞菌是牙周病的主要病原体。这种炎症性疾病广泛存在,并且已将这种疾病与严重的全身性疾病(例如心血管疾病)联系起来。由于对宿主反应中牙龈卟啉单胞菌抗原的免疫调节特性知之甚少,因此了解宿主细胞对牙龈卟啉单胞菌主要抗原的反应(包括激活的信号通路)变得至关重要,以便开发可改善或控制牙周病的新疗法和疫苗。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.
- DOI:10.4049/jimmunol.1003192
- 发表时间:2011-05-15
- 期刊:
- 影响因子:0
- 作者:Gaddis DE;Michalek SM;Katz J
- 通讯作者:Katz J
Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalis.
- DOI:10.1016/j.molimm.2009.05.022
- 发表时间:2009-08
- 期刊:
- 影响因子:3.6
- 作者:Gaddis DE;Michalek SM;Katz J
- 通讯作者:Katz J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jannet Katz其他文献
Jannet Katz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jannet Katz', 18)}}的其他基金
Mechanisms of Immune Modulation and Peridontal Disease
免疫调节与牙周疾病的机制
- 批准号:
6516680 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
6606156 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
7422575 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
7568853 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
7380161 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
6760213 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
7851438 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Peridontal Disease
免疫调节与牙周疾病的机制
- 批准号:
6361859 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
Mechanisms of Immune Modulation and Periodontal Disease
免疫调节与牙周病的机制
- 批准号:
6884589 - 财政年份:2001
- 资助金额:
$ 33.77万 - 项目类别:
MECHANISM(S) OF PROPHYROMONAS GINGIVALIS ADHERENCE
牙龈卟啉单胞菌的粘附机制
- 批准号:
6011653 - 财政年份:1999
- 资助金额:
$ 33.77万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 33.77万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 33.77万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 33.77万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 33.77万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 33.77万 - 项目类别: